Northern Trust’s Sophiris Bio, Inc. SPHS Stock Holding History

Northern Trust’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-70,600	Closed	-$26K	–	4344
2019 Q4	$26K	Hold	70,600	–	–	﹤0.01%	4137
2019 Q3	$41K	Hold	70,600	–	–	﹤0.01%	4074
2019 Q2	$60K	Hold	70,600	–	–	﹤0.01%	4057
2019 Q1	$70K	Hold	70,600	–	–	﹤0.01%	3990
2018 Q4	$59K	Hold	70,600	–	–	﹤0.01%	4024
2018 Q3	$197K	Sell	70,600 -10,000	-12%	-$28.5K	﹤0.01%	3871
2018 Q2	$226K	Buy	80,600 +60,092	+293%	+$179K	﹤0.01%	3819
2018 Q1	$41K	Buy	+20,508	New	+$44.4K	﹤0.01%	4104

Other funds holding SPHS

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

ACM

AUA Capital Management Camp Hill, Pennsylvania $216M AUM 19.17% 1-Year Est. Return

Northern Trust's SPHS Position: Q1 2020 in Review

Northern Trust sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 70,600 shares — an estimated $26K sold.

Northern Trust first reported a position in SPHS in Q1 2018 and held it in 8 quarters. The position peaked at $226K in Q2 2018. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

Northern Trust reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
Northern Trust sold 70,600 Sophiris Bio, Inc. shares in Q1 2020, an estimated $26K.
Northern Trust first reported a position in Sophiris Bio, Inc. in Q1 2018 and held it in 8 quarters.
Northern Trust's Sophiris Bio, Inc. position peaked at $226K in Q2 2018.
3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Northern Trust's 13F filing for Q1 2020, filed 14 May 2020.